Polar Capital Holdings Plc 13D and 13G filings for Summit Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | Summit Therapeutics Inc. SMMT | Polar Capital Holdings Plc | 0 0.000% | -6,295,713 (Position Closed) | Filing |
| 2022-02-14 10:47 am Purchase | 2021-12-31 | 13G | Summit Therapeutics Inc. SMMT | Polar Capital Holdings Plc | 6,295,713 6.400% | 495,713 (+8.55%) | Filing |
| 2021-02-16 07:32 am Purchase | 2020-12-31 | 13G | Summit Therapeutics Inc. SMMT | Polar Capital Holdings Plc | 5,800,000 7.050% | 5,800,000 (New Position) | Filing |